These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 9361191

  • 1. Inducible expression of a mutant form of MEK1 in Swiss 3T3 cells.
    Syu LJ, Guan KL, Saltiel AR.
    J Cell Biochem; 1997 Dec 01; 67(3):367-77. PubMed ID: 9361191
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. MEK1 is required for PDGF-induced ERK activation and DNA synthesis in tracheal myocytes.
    Karpova AY, Abe MK, Li J, Liu PT, Rhee JM, Kuo WL, Hershenson MB.
    Am J Physiol; 1997 Mar 01; 272(3 Pt 1):L558-65. PubMed ID: 9124614
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Reduced requirement of mitogen-activated protein kinase (MAPK) activity for entry into the S phase of the cell cycle in Swiss 3T3 fibroblasts stimulated by bombesin and insulin.
    Seufferlein T, Withers DJ, Rozengurt E.
    J Biol Chem; 1996 Aug 30; 271(35):21471-7. PubMed ID: 8702930
    [Abstract] [Full Text] [Related]

  • 6. Evidence for MEK-independent pathways regulating the prolonged activation of the ERK-MAP kinases.
    Grammer TC, Blenis J.
    Oncogene; 1997 Apr 10; 14(14):1635-42. PubMed ID: 9135064
    [Abstract] [Full Text] [Related]

  • 7. Cot protooncoprotein activates the dual specificity kinases MEK-1 and SEK-1 and induces differentiation of PC12 cells.
    Hagemann D, Troppmair J, Rapp UR.
    Oncogene; 1999 Feb 18; 18(7):1391-400. PubMed ID: 10050876
    [Abstract] [Full Text] [Related]

  • 8. Differential effects on cAMP on the MAP kinase cascade: evidence for a cAMP-insensitive step that can bypass Raf-1.
    Faure M, Bourne HR.
    Mol Biol Cell; 1995 Aug 18; 6(8):1025-35. PubMed ID: 7579705
    [Abstract] [Full Text] [Related]

  • 9. PAK1 phosphorylation of MEK1 regulates fibronectin-stimulated MAPK activation.
    Slack-Davis JK, Eblen ST, Zecevic M, Boerner SA, Tarcsafalvi A, Diaz HB, Marshall MS, Weber MJ, Parsons JT, Catling AD.
    J Cell Biol; 2003 Jul 21; 162(2):281-91. PubMed ID: 12876277
    [Abstract] [Full Text] [Related]

  • 10. The MEK1 proline-rich insert is required for efficient activation of the mitogen-activated protein kinases ERK1 and ERK2 in mammalian cells.
    Dang A, Frost JA, Cobb MH.
    J Biol Chem; 1998 Jul 31; 273(31):19909-13. PubMed ID: 9677429
    [Abstract] [Full Text] [Related]

  • 11. Conditionally oncogenic forms of the A-Raf and B-Raf protein kinases display different biological and biochemical properties in NIH 3T3 cells.
    Pritchard CA, Samuels ML, Bosch E, McMahon M.
    Mol Cell Biol; 1995 Nov 31; 15(11):6430-42. PubMed ID: 7565795
    [Abstract] [Full Text] [Related]

  • 12. Activation of Raf-1/MEK-1/2/p42/44(MAPK) cascade alone is sufficient to uncouple LDL receptor expression from cell growth.
    Kapoor GS, Atkins BA, Mehta KD.
    Mol Cell Biochem; 2002 Jul 31; 236(1-2):13-22. PubMed ID: 12190111
    [Abstract] [Full Text] [Related]

  • 13. Raf-1 is activated by the p38 mitogen-activated protein kinase inhibitor, SB203580.
    Kalmes A, Deou J, Clowes AW, Daum G.
    FEBS Lett; 1999 Feb 05; 444(1):71-4. PubMed ID: 10037150
    [Abstract] [Full Text] [Related]

  • 14. Activation of the mitogen-activated protein kinase/extracellular signal-regulated kinase pathway by conventional, novel, and atypical protein kinase C isotypes.
    Schönwasser DC, Marais RM, Marshall CJ, Parker PJ.
    Mol Cell Biol; 1998 Feb 05; 18(2):790-8. PubMed ID: 9447975
    [Abstract] [Full Text] [Related]

  • 15. Differential contribution of the ERK and JNK mitogen-activated protein kinase cascades to Ras transformation of HT1080 fibrosarcoma and DLD-1 colon carcinoma cells.
    Plattner R, Gupta S, Khosravi-Far R, Sato KY, Perucho M, Der CJ, Stanbridge EJ.
    Oncogene; 1999 Mar 11; 18(10):1807-17. PubMed ID: 10086335
    [Abstract] [Full Text] [Related]

  • 16. MP1: a MEK binding partner that enhances enzymatic activation of the MAP kinase cascade.
    Schaeffer HJ, Catling AD, Eblen ST, Collier LS, Krauss A, Weber MJ.
    Science; 1998 Sep 11; 281(5383):1668-71. PubMed ID: 9733512
    [Abstract] [Full Text] [Related]

  • 17. The effect of cyclic adenosine monophosphate on the mitogen-activated protein kinase pathway depends on both the cell type and the type of tyrosine kinase-receptor.
    Calleja V, Ruiz Enríquez P, Filloux C, Peraldi P, Baron V, Van Obberghen E.
    Endocrinology; 1997 Mar 11; 138(3):1111-20. PubMed ID: 9048617
    [Abstract] [Full Text] [Related]

  • 18. The kinase suppressor of Ras (KSR) modulates growth factor and Ras signaling by uncoupling Elk-1 phosphorylation from MAP kinase activation.
    Sugimoto T, Stewart S, Han M, Guan KL.
    EMBO J; 1998 Mar 16; 17(6):1717-27. PubMed ID: 9501093
    [Abstract] [Full Text] [Related]

  • 19. Selective activation of MEK1 but not MEK2 by A-Raf from epidermal growth factor-stimulated Hela cells.
    Wu X, Noh SJ, Zhou G, Dixon JE, Guan KL.
    J Biol Chem; 1996 Feb 09; 271(6):3265-71. PubMed ID: 8621729
    [Abstract] [Full Text] [Related]

  • 20. Growth hormone-dependent differentiation of 3T3-F442A preadipocytes requires Janus kinase/signal transducer and activator of transcription but not mitogen-activated protein kinase or p70 S6 kinase signaling.
    Yarwood SJ, Sale EM, Sale GJ, Houslay MD, Kilgour E, Anderson NG.
    J Biol Chem; 1999 Mar 26; 274(13):8662-8. PubMed ID: 10085104
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.